Global Generic Drugs Market 2014-2018
As per the analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market. Get Full Details at: http://www.researchbeam.com/global-generic-drugs-2014-2018-market
As per the analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this market. The market is also witnessing an increase in mergers and acquistions. However, intense competition among vendors could squeeze profit margins, increase pricing pressure, and pose a challenge to the growth of this market.
Get Full Details at:
http://www.researchbeam.com/global-generic-drugs-2014-2018-market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Generic</strong> <strong>Drugs</strong><br />
<strong>Market</strong> <strong>2014</strong>-<strong>2018</strong><br />
http://www.researchbeam.com<br />
Published by : Technavio<br />
Date : March <strong>2014</strong><br />
Page : 95<br />
Category: Pharmaceuticals
Report Overview<br />
Research Beam adds a report titled “<strong>Global</strong> <strong>Generic</strong> <strong>Drugs</strong> <strong>Market</strong> <strong>2014</strong>-<strong>2018</strong>” that provides<br />
detailed information of the <strong>Generic</strong> <strong>Drugs</strong> <strong>Market</strong>. The report is an excellent piece of study for<br />
investors who are looking towards the market.<br />
As per the analysts forecast the <strong>Global</strong> <strong>Generic</strong> <strong>Drugs</strong> market to grow at a CAGR of 11.02<br />
percent over the period 2013-<strong>2018</strong>. The patent expiry of top-selling drugs is one of the major<br />
drivers contributing to the growth of this market. The market is also witnessing an increase in<br />
mergers and acquistions. However, intense competition among vendors could squeeze profit<br />
margins, increase pricing pressure, and pose a challenge to the growth of this market.<br />
Detailed Info Available at:<br />
http://www.researchbeam.com/global-generic-drugs-<strong>2014</strong>-<strong>2018</strong>-market
Report Overview<br />
The <strong>Global</strong> <strong>Generic</strong> <strong>Drugs</strong> <strong>Market</strong> <strong>2014</strong>-<strong>2018</strong>, has been prepared based on an in-depth market<br />
analysis with inputs from industry experts. The report covers the market in the Americas, and<br />
the EMEA and APAC regions; it also covers the <strong>Global</strong> <strong>Generic</strong> <strong>Drugs</strong> market landscape and its<br />
growth prospects in the coming years. The report also includes a discussion of the key vendors<br />
operating in this market.<br />
Key vendors dominating this space include Actavis plc, Mylan Inc., Novartis International AG<br />
(Sandoz), STADA Arzneimittel AG, and Teva Pharmaceutical Industries Ltd.<br />
Other vendors mentioned in the report are 3SBio Inc., Amgen Inc., Apotex Inc., AstraZeneca<br />
plc, Aurobindo Pharma Ltd., Baxter International Inc., Berlin-Chemie AG, Biocon Ltd., Biogen<br />
Idec Inc., Boehringer Ingelheim GmbH, Celltrion Inc., Cipla Ltd., Coherus Biosciences Inc.,<br />
Daiichi Sankyo Co. Ltd., Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Ltd., etc.
Report Overview<br />
Key questions answered in this report:<br />
What will the market size and growth rate be in <strong>2018</strong>?<br />
What are the key market trends?<br />
What is driving this market?<br />
What are the challenges to market growth?<br />
Who are the key vendors in this market space?<br />
What are the market opportunities and threats faced by key vendors?<br />
What are the strengths and weaknesses of each of these key vendors?<br />
You can request one free hour of our analyst’s time when you purchase this market report.<br />
Details provided within the report.<br />
Enquire About Report:<br />
http://www.researchbeam.com/global-generic-drugs-<strong>2014</strong>-<strong>2018</strong>-market/enquire-aboutreport
Table of Contents<br />
01. Executive Summary<br />
02. List of Abbreviations<br />
03. Scope of the Report<br />
03.1 <strong>Market</strong> Overview<br />
03.2 Product Offerings<br />
04. <strong>Market</strong> Research Methodology<br />
04.1 <strong>Market</strong> Research Process<br />
04.2 Research Methodology<br />
05. Introduction<br />
06. <strong>Market</strong> Landscape<br />
06.1 <strong>Market</strong> Overview<br />
06.2 <strong>Market</strong> Size and Forecast<br />
06.3 <strong>Generic</strong> <strong>Drugs</strong> <strong>Market</strong> in the US<br />
06.3.1 <strong>Market</strong> Size and Forecast<br />
06.4 <strong>Generic</strong> <strong>Drugs</strong> <strong>Market</strong> in Europe<br />
06.4.1 <strong>Market</strong> Size and Forecast<br />
06.5 <strong>Generic</strong> <strong>Drugs</strong> <strong>Market</strong> in Germany<br />
06.5.1 <strong>Market</strong> Size and Forecast
FOR MORE DETAILS<br />
Visit us at :<br />
http://www.researchbeam.com/global-generic-drugs-<strong>2014</strong>-<strong>2018</strong>-market<br />
Stay With Us:<br />
TELEPHONE: +1 (855) 711-1555<br />
E-MAIL: sales@researchbeam.com<br />
5933 NE Win Sivers Drive,<br />
#205, Portland, OR 97220<br />
United States
Change language